Clinical trials
Cancer clinical trials
Below are recruiting cancer clinical trials, each written for real people, not researchers. We’re tracking 13,068 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06810895Enrolling by invitation
Immunotherapy plus chemo for recurrent cervical cancer
This trial tests a new immunotherapy drug called cadonilimab (AK104) combined with standard chemotherapy for women whose small cell neuroendocrine cervical cancer has returned or spread. The goal is to see if this combination helps shrink tumors or slow the cancer better than chemotherapy alone.
WuhanAges 18–75 - NCT06809673Enrolling by invitation
Blood markers in head and neck cancer surgery
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
GenoaAges 18 years+ - NCT06785922Enrolling by invitation
Stomach bacteria differences in H. pylori patients
This trial compares the types of bacteria in the stomach of people infected with different strains of H. pylori (CagA positive vs. negative). It may help researchers understand how these bacteria affect health.
Bangkok Noi, BangkokAges 18 years+ - NCT06776835Enrolling by invitation
Blood test for better stomach cancer diagnosis
This study is testing whether small molecules in your blood (called 'small non-coding RNAs') can help doctors more accurately diagnose stomach cancer. If you have recently been diagnosed, this study will look for those molecules to see if they can be used as a simple blood test in the future.
Nantong, JiangsuAges 18–85 - NCT06763640Enrolling by invitation
TILs as a predictor in nasopharyngeal cancer
This study looks at how immune cells called TILs (tumor-infiltrating lymphocytes) in your tumor tissue might predict outcomes for nasopharyngeal cancer. It may help doctors better understand your cancer and guide future treatment decisions.
Nanchang, JiangxiAges 18–70 - NCT06752395Enrolling by invitation
Freezing vs. forceps biopsy for small lung nodules
This trial compares two ways of taking a tissue sample from a small lung nodule: traditional forceps (like tiny tweezers) versus a newer freezing method (cryobiopsy). It will help find out which technique is better at getting enough tissue for diagnosis with fewer side effects.
BusanAges 18 years+ - NCT06707714Enrolling by invitation
Metabolic benefits after stomach cancer surgery
This study looks at how stomach cancer surgery affects metabolic syndrome (high blood pressure, diabetes, and related conditions). It aims to understand why some patients see improvements in these conditions after surgery.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06699615Enrolling by invitation
Assessing AI explanations by cancer doctors
This study asks lung cancer doctors at Penn Medicine to look at how an artificial intelligence tool explains its reasoning. The goal is to see if the explanations are clear and helpful for making treatment decisions.
Philadelphia, PennsylvaniaAges Any age - NCT06671418Enrolling by invitationPhase 3
Stenting vs drainage for blocked bile ducts from cancer
This study compares two ways to open blocked bile ducts near the liver due to cancer that cannot be removed. One method uses a stent placed through the skin (percutaneous stenting), and the other uses a tube placed through a scope (endoscopic drainage). The goal is to see which approach works better for relieving jaundice and improving quality of life.
RotterdamAges Any age - NCT06652295Enrolling by invitation
Self-physiotherapy for lymphedema
This trial tests whether a self-guided physiotherapy program can help manage lymphedema (arm swelling) after breast cancer treatment. If you have had breast cancer-related lymphedema for a while and haven't had recent treatment for it, this study may offer a way to take control of your symptoms.
IzmirAges 18–65 - NCT06584994Enrolling by invitation
Genetics and cancer risk in families
This study looks at how genes passed down in families might increase the chance of getting cancer. It collects samples from children with cancer and their family members to better understand cancer risks.
CambridgeAges Any age - NCT06565585Enrolling by invitation
Predicting cancer return after penis-sparing surgery for penile cancer
This study looks at how often penile cancer comes back after low-risk, penis-sparing surgery and how that affects long-term health. It may help doctors understand which patients need closer follow-up.
LeuvenAges 18 years+ - NCT06544798Enrolling by invitationPhase 2
Long-term follow-up of gene therapy for dry mouth
This study follows patients who previously received gene therapy for dry mouth caused by radiation. It aims to track long-term safety and any lasting benefits.
Gilbert, ArizonaAges 18 years+ - NCT06541821Enrolling by invitation
A Study on Activity and Stoma Care in Urostomy Patients
This study looks at how physical activity, fear of movement, and stoma care relate to each other in people who have had urostomy surgery for bladder cancer. It aims to help understand what affects your daily life and care after surgery.
Konya, SelçukluAges 40–75 - NCT06540508Enrolling by invitation
TACE with targeted immunotherapy for advanced liver cancer
This study looks at whether combining a liver-directed procedure called TACE with tiragolumab and targeted therapy works better for people with unresectable liver cancer that has not spread too far. Researchers will use blood and tissue tests to see how well the treatment works.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06472817Enrolling by invitation
Social factors affecting prostate cancer care in African and Caribbean men
This study looks at how social and cultural factors affect prostate cancer care and long-term health in Black immigrant men from Sub-Saharan Africa and the Caribbean. Your experiences can help improve cancer care for others like you.
Atlanta, GeorgiaAges 18 years+ - NCT06472765Enrolling by invitation
Study of the Vaginal Ecosystem in Healthy Women
This study looks at the natural balance of bacteria and other factors in the vagina of healthy women. It aims to learn more about what a healthy vaginal ecosystem looks like.
Fullerton, CaliforniaAges 18–89 - NCT06462521Enrolling by invitation
Comparing two ways to remove large polyps during a colonoscopy
This study compares two methods for removing larger polyps (flat growths) found during a colonoscopy. It tests if one technique works as well or better than the other for people with certain types of polyps.
Indianapolis, IndianaAges 18 years+ - NCT06419179Enrolling by invitationPhase 2
Maintenance therapy for HRD-positive small-cell lung cancer
This trial tests whether a combination of two medications, durvalumab and olaparib, can help keep your extensive-stage small-cell lung cancer from coming back after standard first-line treatment. It is for people whose tumors have a specific genetic feature called HRD.
Cologne, North Rhine-WestphaliaAges 18–120 - NCT06405295Enrolling by invitation
Intensive adjuvant therapy for BRCA-related triple-negative breast cancer
This trial tests an intensive add-on treatment for people with triple-negative breast cancer and a BRCA mutation who are at high risk of recurrence after surgery and standard treatments. The goal is to see if extra therapy helps prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT06306274Enrolling by invitationPhase 2/Phase 3
Tacrolimus cream for breast cancer-related lymphedema
This study tests if a cream called tacrolimus can help reduce swelling in the arm caused by breast cancer treatment (lymphedema). It is looking for women with mild to moderate swelling that has not yet caused severe skin changes.
OdenseAges 18 years+ - NCT06298149Enrolling by invitation
Turtle Island Tales health program for families
This study tests a program called Turtle Island Tales for caregivers and young children living in certain high-poverty areas. It aims to see if the program helps families be healthier and happier.
Bozeman, MontanaAges 18 years+ - NCT06296641Enrolling by invitation
Needs navigation support for caregivers of teens and young adults with cancer
This study tests a program that helps caregivers of teens and young adults (AYAs) with cancer find and access the support they need. If you are the parent or financial partner of an AYA who was diagnosed in the last 3 months to just finishing treatment, this trial might offer helpful resources.
New York, New YorkAges 15–26 - NCT06281964Enrolling by invitationPhase 3
New pill for EGFR Exon 20 lung cancer
This study tests a new pill called PLB1004 for people whose lung cancer has a specific EGFR mutation (exon 20 insertion). It is for those who have not yet had any treatment for their advanced cancer.
Guangzhou, GuangzhouAges 18 years+
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer?
- Yes. Clin2 currently lists 13,068 recruiting cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Stand Up To CancerPeople facing cancer across many types, through the research that leads to better treatments.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.